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Abstract
Latin America and the Caribbean region make up one of the largest areas of the world, and this region is character-
ized by a complex mixture of ethnic groups sharing Iberian languages. The area is comprised of nations and regions
with different levels of social development. This region has experienced historical advances in the last decades to in-
crease the minimal standards of quality of life; however, several factors, such as concentrated populations in large
urban centers and isolated and poor communities, still have an important impact on medical services, particularly ge-
netics services. Latin American researchers have greatly contributed to the development of human genetics and his-
toric inter-ethnic diversity, and the multiplicity of geographic areas are unique for the study of gene-environment
interactions. As a result of regional developments in the fields of human and medical genetics, the Latin American
Network of Human Genetics (Red Latinoamericana de Genética Humana - RELAGH) was created in 2001 to foster
the networking of national associations and societies dedicated to these scientific disciplines. RELAGH has devel-
oped important educational activities, such as the Latin American School of Human and Medical Genetics (ELAG),
and has held three biannual meetings to encourage international research cooperation among the member countries
and international organizations. Since its foundation, RELAGH has been admitted as a full regional member to the In-
ternational Federation of Human Genetics Societies. This article describes the historical aspects, activities, develop-
ments, and challenges that are still faced by the Network.
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Background
Latin America and the Caribbean region is composed
of 32 countries and Puerto Rico, an unincorporated territory
of the United States. Twenty of these countries share a com-
mon history and culture resulting from the Iberian coloni-
zation in the 16th century and are characterized by the use of
the Spanish and Portuguese languages. The region covers
an area of 21,069,501 km2 (14.1% of earth’s land surface
area) and is populated by 581.4 million people (8.3% of the
world population), with approximately 79% of the people
living in urban areas concentrated in the Atlantic coastal re-
gions, the Central Valley of Mexico, the Andean moun-
tains, Central America and the main Caribbean islands;
overall, this area has a per capita gross national income
(GNI) of US$ 8,981. This territory constitutes one of the
largest linguistic and culturally cohesive regions in the
planet and represents the 4th largest economy in the world
(Latin America and the Caribbean (LAC) Population Data-
base, 2005; Almanaque Mundial 2013, 2012; The World
Bank, 2013).
The Human Development Report 2013 of the United
Nations Development Program showed that the majority of
the countries in Latin America and the Caribbean have
reached a Human Development Index (HDI) of 0.741,
which is considered a high HDI; however, several countries
in the area exhibit a medium HDI (Human Development
Report, 2013). This index suggests that the population in
the region has reached an acceptable quality of social wel-
fare and acceptable medical services, including pre-natal
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and perinatal screening, fetal medicine, medical genetics
services, and sophisticated molecular and genetics diagnos-
tics laboratories; however, the region still suffers from im-
portant income inequalities and has the most unequal
income distribution worldwide (Human Development Re-
port, 2013). Important sub-regional differences exist in ev-
ery country of the region, even in countries with a very high
HDI. Health services are concentrated in the primary urban
centers, and there is a substantial lack of primary health-
care centers in the rural areas to provide quality medical at-
tention; additionally, almost no genetic services are avail-
able in several regions and countries (Penchaszadeh, 2004).
As with the health systems, the universities and research
centers are also located in the main metropoles; however,
the region stills suffers from minimal financial resources
for research, low academic-entrepreneurial interactions
and small inter-academic cooperation to develop research.
Nevertheless, several governments are starting to support
research activities, and several institutions with well-
trained scientists and sufficient infrastructure are perform-
ing genomic research, primarily in countries such as Brazil,
Mexico, Argentina, and Chile.
The activities in the fields of human genetics and
medical genetics in Latin America and the Caribbean began
in the 1950-60s. Several original clinical descriptions of
Beguez-Chédiak–Higashi syndrome (OMIM #214500),
Cantú syndrome (OMIM #239850), congenital generalized
hypertrichosis (OMIM #307150), Grebe-Quelce-Salgado
syndrome (OMIM #200700), acheiropodia (OMIM
#200500), Yunis-Varon syndrome (OMIM #216340),
IVIC Syndrome (OMIM #147750), odontotrichomelic syn-
drome (OMIM #273400), and several camptodactyly asso-
ciated syndromes, among others [Online Mendelian Inheri-
tance in Man (OMIM)], were first described by Latin
America geneticists; additionally, several regional hemo-
globinopathies have been described and characterized.
These scientists have also described notable genetic pheno-
types clusters or large pedigrees for Huntington’s disease in
Maracaibo (Negrette, 1963), Laron syndrome in Ecuador
(Berg et al., 1992), early-onset Alzheimer’s disease in Co-
lombia (Lopera et al., 1997), Jarcho-Levin syndrome in
Puerto Rico (Cornier et al., 2004), twin births in Brazil
(Tagliani-Ribeiro et al., 2012), and actinic prurigo in sev-
eral American-aboriginal communities, among others. La-
tin American geneticists also established remarkable birth
defect registries, including the Estudio Colaborativo Latino
Americano de Malformaciones Congénitas (ECLAMC) by
Dr. Eduardo Castilla in South America and the Registro y
Vigilancia Epidemiológica de Malformaciones Congénitas
Externas (RIVEMCE) by Dr. Osvaldo Mutchinick in Mex-
ico. These registries are crucial for the understanding of
several complex congenital diseases, such as orofacial
clefts and neural tube defects, and several local studies have
demonstrated that folic acid supplementation can help pre-
vent neural tube defects. Several countries have national
newborn screening programs, with very high coverage by
comprehensive panels in Costa Rica, Chile, and Uruguay.
The detection of congenital hypothyroidism has been effec-
tively attempted by newborn screening programs in several
Latin American countries. Population geneticists have
greatly contributed to the genetic studies of the aboriginal
and modern Latin American and Caribbean populations.
Finally, for the research of complex prevalent diseases,
such as diabetes, cardiovascular disorders, psychiatric dis-
eases, birth defects, and cancer, and for pharmacogenomic
studies, the region offers unique conditions that are not
present in the rest of the world, including environmental di-
versity, ethnic diversity, population structure, and a high
rate of environmental exposures. This scenery favors the
study of gene-environment interactions, and several admix-
ture studies have analyzed the genetic factors involved in
complex phenotypes.
All of these developments and the promissing prog-
ress in the field of human and medical genetics inspired
several of the founders and leaders of these disciplines in
this region to create the Red Latinoamericana de Genética
Humana (RELAGH) in the early 1990s, with the aim of cre-
ating a network for human genetics researchers, students,
and practitioners in Latin America and the Caribbean; the
goal of this network was to contribute to the development
of collaborative projects for education, research and assis-
tance, and to represent the region before the International
Federation of Human Genetics Societies (IFHGS).
The Foundation of RELAGH
The idea of creating a Latin American Network of
Human Genetics (RELAGH) arose during the IX Interna-
tional Congress of Human Genetics in 1996 in Rio de Ja-
neiro, Brazil, at which the International Federation of
Human Genetic Societies was created. Several Latin Amer-
ican societies of human and medical genetics applied for
membership to the new organization. After establishing
that the Executive Committee of the IFHGS would include
representatives of societies in Europe, United States, Can-
ada, Australia, and Asia as full members, this committee
suggested that Latin America could form a regional repre-
sentative group. In 1997, a meeting was held in San Juan de
el Río, Queretaro, Mexico; at this time, representatives of
the human genetics field from a dozen Latin American
countries, and Dr. Marcus Pembrey, the IFHGS representa-
tive, organized RELAGH, stating that such a network
would represent not only human genetics societies, but also
persons in those countries that do not have associations or
societies.
A meeting in 1999 in Buenos Aires, Argentina, pri-
marily attended by ECLAMC members, resulted in the
nomination of an Organizing Committee that consisted of
representatives from Brazil, Argentina, and Mexico. Sev-
eral difficulties were overcome in the following years;
therefore, in Vienna, Austria, during the 10th International
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Congress of Human Genetics in May 2001, RELAGH was
formally established through the participation of the Presi-
dents of five groups: the branch of Human Genetics of the
Sociedad Argentina de Genética, the Sociedade Brasileira
de Genética Médica, the Asociación Colombiana de Gené-
tica Humana, the Asociación Mexicana de Genética Huma-
na, and the Sociedad Panameña de Genética Humana.
Dr. José María Cantú (Mexico) was appointed the Acting
President for two years, and he agreed to create an assembly
to evaluate the proposed governing statutes of RELAGH
and chose the first Board of Directors. Dr. Roberto Giu-
gliani (Brazil) was proposed as the RELAGH operator.
During the IFHGS meeting at the same Congress,
RELAGH was accepted as a full member and part of its Ex-
ecutive Committee.
In 2003, a new Board of Directors was appointed dur-
ing the Presidency of Roberto Giugliani (Brazil). This
board decided to form an Executive Committee to address
the practical activities of the young network. This commit-
tee was based in Porto Alegre, Brazil and was formed by
Roberto Giugliani and Ursula Matte (Chairpersons). The
primary goals for this period were to draft and propose the
bylaws of the network; to consolidate RELAGH as a repre-
sentative of Latin America in the IFHGS; to set up the net-
work website and use it as the main communication tool
between RELAGH members; to expand the RELAGH
membership, and promote RELAGH as a hub for collabo-
ration among human genetics groups in the Latin American
region; and to organize the Latin American School of Hu-
man and Medical Genetics (ELAG). Having achieved all of
these goals, the RELAGH presidency was transferred to the
new board of directors in 2006 (no business meeting was
held in 2005). The Executive Committee decided to con-
tinue its activity and became the Organizing Committee of
the ELAG, which has been a very successful course since
2005.
The bylaws of the network were initially established
in March 2004 and modified in 2008 during the First Latin
American Congress of Human Genetics in Cartagena, Co-
lombia. Thereafter, RELAGH has been led by the follow-
ing presidents: Dr. Alejandro Giraldo-Ríos (2006-2008),
Dr. Gerardo Jiménez-Arce (Costa Rica, 2008-2011), and
Dr. Augusto Rojas-Martínez (Mexico, 2011-2013);
RELAGH is currently led by Dr. Aída Falcón de Vargas
(Venezuela, 2013-2015).
The Latin American School of Human and
Medical Genetics (ELAG)
Short courses in medical and human genetics are al-
ready offered to young students and professionals in North
America (the Bar Harbor course on Mammalian Genetics)
and Europe (The European School of Medical Genetics).
Young researchers and professionals in Latin America
should also be prepared to address the challenges of in-
creased genetic applications in health sciences.
The aim of ELAG is to promote a one-week “state of
the art” Human and Medical Genetics course that will ex-
pose a selected number of top-grade students to first rank
researchers in the field. In addition to attending a strong
teaching program, the students have the unique opportunity
of discuss projects, techniques, clinical cases, and scientific
issues with the faculty members. The participation of stu-
dents and faculty members from several Latin American
countries stimulates further cooperation between the
groups inside the continent. During this course, new con-
nections are created, and new opportunities are opened.
The target audience includes PhD students, post-docs, and
young physicians interested in the fields of human and
medical genetics. The students are selected on the basis of a
broad participation of Latin American countries and on
their individual performance according to academic re-
cords, curriculum vitae, and recommendation letters. The
ELAG faculty consists of top rank scientists from Latin
America, North America and Europe who are invited to
lead lectures and courses. On-site accommodations are an
important point, as informal contact between students and
faculty is one of the major goals of this initiative. Regard-
ing the financing of ELAG activities, the organizers apply
to governmental organizations, research funding agencies,
and companies to obtain the financial support for the fac-
ulty expenses, including transport, accommodation and
meals, and to grant a limited number of competitive fellow-
ships to students. The organizers also encourage the na-
tional agencies of Latin American countries to grant
fellowships to cover student expenses.
The first ELAG course was held in 2005, and this
course has been repeated every year. With the exception of
2007, when it was held in Angra dos Reis (200 km from Rio
de Janeiro), all of the courses have been held at Hotel
Samuara in Rio Grande do Sul, Brazil. This hotel is located
inside a natural park, 10 km from the city of Caxias do Sul
and 100 km from Porto Alegre, and provides a perfect envi-
ronment for the development of this activity. Each course
has 70-75 students that come from 10-15 different Latin
American countries and 25-30 faculty members from Latin
America, North America, and Europe.
Latin American Meetings of Human Genetics
The first Latin American Congress of Human Genet-
ics (CLAGH) was co-organized between RELAGH and the
Asociación Colombiana de Genética Humana and was cel-
ebrated in Cartagena, Colombia in October 2008. The
meeting was attended by human and medical geneticists
and many students from almost all of the region. A work-
shop on laboratory standards, organized by Dr. Jean-
Jacques Cassiman, in representation of the EurogenTest,
was held to contribute to the understanding of quality assur-
ance norms and ethical standards that have been established
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by this European organization. The meeting was a very suc-
cessful effort to launch research and academic activities in
the region. During the business meeting, the bylaws of the
Network were modified, and the presidency was handed
over to Dr. Gerardo Jiménez-Arce (Costa Rica).
The 2nd CLAGH occurred in San José Costa Rica in
May, 2011 and was co-organized by RELAGH and the
Universidad de Costa Rica and the Colegio de Biólogos de
Costa Rica, and was financed, in part, by the National Min-
istry of Science and Technology. The meeting began with a
lecture by Dr. Judith Hall, president of IFHGS. During this
event, the Universidad de Costa Rica granted the Doctor
honoris causa title to Dr. Francisco M. Salzano (Brazil) for
his contributions in the development of the Population Ge-
netics in Latin America. Again, the EurogenTest Organiza-
tion offered a workshop, which was conducted by Dr. Gert
Matthijs. The Human Variome Project Organization (HVP)
held a meeting, which was presided over by Dr. Richard G.
Cotton, the founder of the project, to encourage the partici-
pation of Latin America in this project. During the business
meeting, the RELAGH presidency was handed over to Dr.
Augusto Rojas-Martínez (Mexico).
Due to the invitation of Dr. Cotton, an inter-insti-
tutional Mexican group created the first Latin American
Node of the HVP in June 2012. The Node received finan-
cial support from the Centro de Investigación y
Desarrollo en Ciencias de la Salud of the Universidad
Autónoma de Nuevo León in Monterrey, in which the
bioinformatics group coordinates the collection of rele-
vant national data. A second HVP Node was launched in
March 2013 in Venezuela, under the leadership of Dr.
Aída Falcón de Vargas.
The 3rd CLAGH was held in November 2012 in the
Riviera Maya, Mexico. The meeting was co-organized by
the Asociación Mexicana de Genética Humana, which
also celebrated the 38th Mexican Meeting of Human Ge-
netics. The meeting was attended by more than 800 partic-
ipants, including more than 70 lecturers by researchers
from the USA, Europe, Australia, Latin America and the
Caribbean and included the attendance of Dr. Stephen
Lam, President of IFHGS. In addition to six plenary lec-
tures, a total of six workshops, 11 symposia, 80 oral, and
293 poster presentations were contributed by researchers
from almost all of the Latin America and Caribbean coun-
tries. These events covered the topics of medical genetics,
cytogenetics, complex diseases, population genetics, mo-
lecular biology, genetic epidemiology, and cancer. A
3-day workshop on Public Health Genomics, financed by
the Consejo Nacional de Ciencia y Tecnología (Mexico),
was conducted as a preamble for the 3rd CLAGH. This
workshop introduced the concept of using genomic infor-
mation for public health purposes to improve preventive
care. Lecturers for this workshop included leading scien-
tists from the fields of public health, medical genetics, hu-
man genomics, and bioinformatics from the USA, Europe,
Argentina, Brazil, and Mexico. The HVP held a special
symposium to promote the creation of more HVP country
nodes in the region. During this meeting, the General As-
sembly of RELAGH examined the status of the Network,
including the rules for membership, and elections were
performed to form the new Board. The Presidency was
handed over to Dr. Aída Falcón de Vargas (Venezuela),
and Dr. Lavínia Schüler-Faccini (Brazil) was elected as
vice-president of the Network for the period of
2014-2015. This meeting showcased new technologies,
including next generation sequencing and microarray
platforms, that can facilitate genomic research studies of
monogenic, chromosomal, and complex diseases, as well
as made efforts to introduce these technologies into the
clinic for diagnostic purposes.
Challenges
Despite the progress that has been made, the Network
is presently consists of national associations, societies, and
sections of human and medical genetics from 13 countries
(Argentina, Brazil, Bolivia, Chile, Colombia, Costa Rica,
Cuba, Ecuador, Mexico, Panama, Peru, Uruguay, and Ven-
ezuela). Associations from Nicaragua, and Paraguay de-
clared their interest in joining RELAGH during the last
meeting held in the Riviera Maya, and these associations
will most likely be included during the current presidency.
This interest implies that RELAGH should increase its ef-
forts to network with the associations of several countries
in Central America and the Caribbean.
Having decided since the very beginning to not col-
lect fees from its members, RELAGH faces a continuous
challenge in obtaining funding to support its activities.
Obtaining funding has been accomplished with the help of
the affiliated national societies, whose support has en-
abled RELAGH to conduct its meetings. However, more
stable funding should be pursued to enable the develop-
ment of projects that are aimed at establishing stronger
connections between its members, such as regular news-
letters, online educational projects, the maintenance of an
updated database of research groups and services pro-
vided in the region, training/exchange programs, and
other possibilities.
Finally, the integration of available human resources
and infrastructure in the region remains a challenge. Al-
though this ability may compensate for the lack of profes-
sional and laboratory services in several countries and
regions, ignorance about resources, the lack of communica-
tion and logistic, and administrative limitations, such as
courier services and national customs, still restrict efficient
international cooperation. The implementation of national
directories of medical genetics services and diagnostic lab-
oratories may be a step forward in accomplishing these
tasks, and the current presidency of the RELAGH is work-
ing towards this goal.
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